首页> 外文期刊>The Turkish journal of pediatrics. >The impact of 21-hydroxylase deficiency on cardiac repolarization changes in children with 21-hydroxylasedeficient congenital adrenal hyperplasia
【24h】

The impact of 21-hydroxylase deficiency on cardiac repolarization changes in children with 21-hydroxylasedeficient congenital adrenal hyperplasia

机译:21-羟化酶缺乏对21-羟化酶缺乏先天性增生的儿童心脏再渗变变化的影响

获取原文
           

摘要

21-hydroxylase-deficient congenital adrenal hyperplasia (CAH) is associatedwith cardiovascular risk factors such as, hypertension, obesity, dyslipidemia,and insulin resistance. It is not known whether 21-hydroxylase-deficient CAHis risk factor for atrial and ventricular arrhythmias. The purpose of this studywas to compare the 12-lead electrocardiographic measures in patients of21-hydroxylase-deficient congenital adrenal hyperplasia with those in healthycontrol subjects matched for age, sex, height, weight and body mass index(BMI). Twenty-five patients with 21-hydroxylase-deficient CAH and twenty-fiveheathy control subjects were enrolled into this observational, cross-sectional,controlled study. The evaluation consisted of anthropometric measurements,biochemical parameters, and electrocardiographic (ECG) measures. The standard12-lead electrocardiography was performed in all patients and P-wave dispersion(PWd), QT interval, QTd, QTcd, Tp-e dispersion, Tp-e/QT and Tp-e/QTcratios were calculated. There were no significant differences in the groups forage, sex, height, weight and BMI (median age 9.4 (1.5–16.75) years, meanweight 37.6±21.5 vs. 27.9±18.3 kg, mean height 125.4±28.9 vs. 114.7±31cm, mean BMI 21.4±5.7 vs. 18.9±3.4 kg/m2, respectively). P dispersion andTp-e dispersion were significantly higher in patients of 21-hydroxylase-deficientCAH compared to the healthy subjects (median P dispersion 50 (25) vs.40 (40) ms, mean Tp-e dispersion 48±15.5 vs. 35.2±17.5 ms). Our studyrevealed that 21-hydroxylase deficient CAH is associated with high risk ofatrial and ventricular arrhythmias in children.
机译:21-羟化酶缺乏先天性增生增生(CAH)与心血管危险因素相关,如高血压,肥胖,血脂血症和胰岛素抵抗力。尚不清楚21-羟基化酶缺陷性Cahis风险因素是否适用于心房和心律失常。该研究的目的是比较21-羟化酶缺乏先天性肾上腺增生患者的12-铅心电图措施,与年龄,性别,高度,体重和体重指数(BMI)匹配的健康核毒素受试者。 25例患有21例羟化酶缺陷的CAH和二十五个eAthy对照受试者的患者注册了该观察,横截面,受控研究。评估由人类测量测量,生化参数和心电图(ECG)措施组成。在所有患者和P波分散(PWD)中进行了标准的12-铅心电图,计算了QT间隔,QTD,QTCD,TP-E分散,TP-E分散,TP-E / QT和TP-E / QT和TP-E分散。饲料,性别,高度,重量和BMI(中位年龄9.4(1.5-16.75)多年没有显着差异,平均37.6±21.5与27.9±18.3千克,平均高度125.4±28.9与114.7±31cm,平均BMI 21.4±5.7与18.9±3.4 kg / m2)。与健康受试者相比,21-羟化酶 - 缺陷型患者的P分散和分散体显着高于21-羟化酶 - 缺陷菌(25)vs.40(40)MS,平均TP-E分散48±15.5与35.2±± 17.5毫秒)。我们的StudyReveped认为21-羟化酶缺陷CaH与儿童的高风险和室性心律失常相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号